Qualigen Therapeutics
QLGN
QLGN
27 hedge funds and large institutions have $5.11M invested in Qualigen Therapeutics in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 0.01% → 0.01% (+0.01%)
90% less call options, than puts
Call options by funds: $205K | Put options by funds: $2.14M
Holders
27
Holding in Top 10
–
Calls
$205K
Puts
$2.14M
Top Buyers
| 1 | +$486K | |
| 2 | +$294K | |
| 3 | +$290K | |
| 4 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
+$216K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$158K |
Top Sellers
| 1 | -$188K | |
| 2 | -$92K | |
| 3 | -$48K | |
| 4 |
Charles Schwab
San Francisco,
California
|
-$47K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$11K |